 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
12-13-2023
Insider Buy |
Eric Bjerkholt
Director |
$1.62
CAGR »
|
$16,200.00
10,000 shares |
8-21-2023
Insider Buy |
Eric Bjerkholt
Director |
$1.72
CAGR »
|
$17,151.00
10,000 shares |
8-22-2023
Insider Buy |
Ann Lucena
Director |
$1.69
CAGR »
|
$12,637.50
7,500 shares |
5-26-2023
Insider Buy |
Daniel N. Swisher Jr.
Director |
$1.91
CAGR »
|
$9,535.00
5,000 shares |
5-24-2023
Insider Buy |
Gail Schulze
Director |
$2.03
CAGR »
|
$19,980.72
9,850 shares |
5-23-2023
Insider Buy |
Eric Bjerkholt
Director |
$2.00
CAGR »
|
$10,000.00
5,000 shares |
2-11-2020
Insider Buy |
Timothy L. Moore
Director |
$4.75
CAGR »
|
$17,165.05
3,614 shares |
1-29-2020
Insider Buy |
Daniel N. Swisher Jr.
Director |
$4.15
CAGR »
|
$4,150.00
1,000 shares |
1-29-2020
Insider Buy |
Eric Bjerkholt
Director |
$4.15
CAGR »
|
$83,000.00
20,000 shares |
1-29-2020
Insider Buy |
Frank Witney
Director |
$4.15
CAGR »
|
$99,998.40
24,096 shares |
1-29-2020
Insider Buy |
Jami K. Nachtsheim
Director |
$4.15
CAGR »
|
$10,001.50
2,410 shares |
1-29-2020
Insider Buy |
Timothy B. Anderson
Director |
$4.15
CAGR »
|
$40,001.85
9,639 shares |
6-4-2019
Insider Buy |
William Mariner Greenman
President and CEO |
$4.60
CAGR »
|
$46,000.00
10,000 shares |
8-20-2015
Insider Buy |
Laurence M. Corash
Chief Scientific Officer |
$4.95
CAGR »
|
$96,503.55
19,500 shares |
8-19-2015
Insider Buy |
Laurence M. Corash
Chief Scientific Officer |
$4.99
CAGR »
|
$129,233.23
25,900 shares |
8-18-2015
Insider Buy |
Laurence M. Corash
Chief Scientific Officer |
$4.77
CAGR »
|
$403,464.79
84,600 shares |
8-13-2015
Insider Buy |
Laurence M. Corash
Chief Scientific Officer |
$4.98
CAGR »
|
$249,045.00
50,000 shares |
8-12-2015
Insider Buy |
Laurence M. Corash
Chief Scientific Officer |
$4.82
CAGR »
|
$120,550.00
25,000 shares |
11-16-2012
Insider Buy |
Laurence M. Corash
Chief Medical Officer |
$2.85
CAGR »
|
$5,698.00
2,000 shares |
Also See: Institutional Holders of CERS
Also See: SEC filings
Below we present the annualized performance delivered by CERS stock since 12-13-2023 (the date of the most recent
insider purchase). The performance of the investment from the time CERS insider buying occurred is the ultimate
test of whether insiders were right about CERS being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/14/2023 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$2.06 |
|
| End price/share: |
$1.70 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-17.48% |
|
| Annualized Gain: |
-48.32% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,252.00 |
|
| Years: |
0.36 |
|
CERS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent CERS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CERS
|
|
Free CERS Email Alerts:
